Author

Martine De Vos 1

1 Gent University

The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease

Marcus Harbord, Vito Annese, Stephan Vavricka, Matthieu Allez, Manuel Barreiro de Acosta, Kirsten Muri Boberg, Johan Burisch, Martine De Vos, Annemarie De Vries, Andrew Dick, Pascal Juillerat, Tom Hemming Karlsen, Ioannis Koutroubakis, Peter L Lakatos, Timothy Orchard, Pavol Papay, Tim Raine, Max Reinshagen, Diamant Thaci

Athritis, arthralgias and metabolic bone disease: Therapeutic considerations

Martine De Vos

Clinical case: An IBD patient with arthralgia & How do guidelines help us?

Axel Dignass, Martine De Vos

CHARACTERISTICS OF CHILDREN WITH CROHN?S DISEASE FAILING SUSTAINED REMISSION DESPITE ANTI-TNF EXPOSURE

Lucas Wauters, Françoise Smets, Ilse Hoffman, Elisabeth De Greef, Patrick Bontems, Philippe Alliet, Wim Arts, Bruno Hauser, Stephanie Van Biervliet, Els Van de Vijver, Isabelle Paquot, Harald Peeters, Peter Bossuyt, Jean François Rahier, Tom Moreels, Olivier Dewit, Denis Franchimont, Vinciane Muls, Fernand Fontaine, Edou

OPEN LABEL OBSERVATIONAL STUDY EVALUATING THE EFFECT OF INDUCTION THERAPY WITH VEDOLIZUMAB IN PATIENTS WITH MODERATE TO SEVERE INFLAMMATORY BOWEL DISEASE INTOLERANT/RESISTANT TO AT LEAST TWO BIOLOGICALS

Martine De Vos, Barbara Dhooghe, Severine Vermeire, Edouard Louis, Mana Fazia, An Elewaut, Peter Bossuyt, Filip Baert, Catherine Reenaers, Marc Van Gossum, Elisabeth Macken, Marc Ferrante, Pieter Hindryckx, Sophie De Wit, Tom Holvoet, Denis Franchimont

Open label observational study evaluating the effect of induction therapy with vedolizumab in patients with moderate to severe inflammatory bowel disease intolerant/resistant to at least two biologicals

Martine De Vos

GENOME-WIDE COPY NUMBER VARIATION SCAN IDENTIFIES COMPLEMENT COMPONENT C4 AS NOVEL SUSCEPTIBILITY GENE FOR CROHN’S DISEASE

Isabelle Cleynen, Peter Konings, Emilie Théatre, Leila Amininejad, Debby Laukens, Nooshin Ardeshir Davani, Harry Cuppens, Kathleen Machiels, Tamara Coopmans, Caroline Robberecht, Willem-Jan Wollants, Karolien Claes, Sophie Organe, Paul Rutgeerts, Denis Franchimont, Martine De Vos, Edouard Louis, Kristel Van Steen, Michel

ACCELERATED STEP-UP APPROACH AND LONG-TERM DISEASE OUTCOMES IN PAEDIATRIC PATIENTS WITH CROHN?S DISEASE

Lucas Wauters, Françoise Smets, Ilse Hoffman, Elisabeth De Greef, Patrick Bontems, Philippe Alliet, Wim Arts, Bruno Hauser, Stephanie Van Biervliet, Els Van de Vijver, Isabelle Paquot, Harald Peeters, Peter Bossuyt, Jean François Rahier, Tom Moreels, Olivier Dewit, Denis Franchimont, Vinciane Muls, Fernand Fontaine, Edou

LONG-TERM OUTCOMES OF TOP-DOWN VERSUS STEP-UP TREATMENT IN NEWLY DIAGNOSED CROHN’S DISEASE

Daniël Robin Hoekman, Judith Stibbe, Filip Baert, Philip Caenepeel, Philippe Vergauwe, Martine De Vos, Adriaan van Bodegraven, Severine Vermeire, Geert R. D'Haens

SILENCING OF PROLYL HYDROXYLASE 1 IN INTESTINAL MICROVASCULAR ENDOTHELIAL CELLS PREVENTS INFLAMMATION-INDUCED ENDOTHELIAL DYSFUNCTION AND DAMPENS MURINE COLITIS.

Sophie van Welden, Debby Laukens, Lindsey Devisscher, Carmen Correale, Silvia D´Alessio, Silvio Danese, Martine De Vos, Pieter Hindryckx

Item 1 - 10 / 11
1
2